Oral zamicastat

DRUG2 trials

Sponsors

Bial - Portela C S.A.

Conditions

Pulmonary Arterial Hypertension

Phase 2

Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat)

CompletedNCT04316143

Bial - Portela C S.A.Pulmonary Arterial Hypertension

Start: 2019-06-03End: 2021-10-20Updated: 2024-10-15

Safety and Efficacy of BIA 5-1058 in PAH

CompletedNCT06009185

Bial - Portela C S.A.Pulmonary Arterial Hypertension

Start: 2019-06-26End: 2022-02-17Updated: 2023-09-01